Friday, March 13, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Israeli health minister: Room for COVID optimism as ‘R’ drops to 0.8

“There is room for optimism,” said Health Minister Nitzan Horowitz Friday morning in a Facebook post soon after his ministry updated that the country’s reproduction rate had dropped to 0.8.
The reproduction rate or “R” is the number of people a sick person infects. It has been declining for several days now, Friday morning reaching the target that decision makers had said previously would halt the spread of coronavirus.

“The low reproduction rate provides sufficient safety margins to prevent the resumption of the outbreak as a result of the opening of the education system,” a team of Hebrew University researchers that advise the government said on Friday in a report.

Source: The Jerusalem Post

https://www.jpost.com/breaking-news/covid-numbers-nearly-8000-cases-yesterday-but-r-at-08-679127

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

2027 Medicare Advantage & Part D Advance Notice

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!